TrialJournal of the Pediatric Infectious Diseases Society2024

Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season.

Ron Dagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.